# Effects of Dexmedetomidine on Delirium After Living Donor Renal Transplantation in Adult Patients

> **NCT02509949** · PHASE4 · UNKNOWN · sponsor: **Tao Zhang** · enrollment: 100 (estimated)

## Conditions studied

- Postoperative Delirium After Living Donor Renal Transplantation

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT02509949
- **Lead sponsor:** Tao Zhang
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-05
- **Primary completion:** 2019-09
- **Final completion:** —
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2018-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02509949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02509949, "Effects of Dexmedetomidine on Delirium After Living Donor Renal Transplantation in Adult Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02509949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*